Clinical Differences of Recent Myocardial Infarction Compared With Acute Myocardial Infarction - Insights From the Tokyo CCU Network Multicenter Registry.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 08 2020
Historique:
pubmed: 28 7 2020
medline: 14 10 2021
entrez: 28 7 2020
Statut: ppublish

Résumé

Characteristics and treatment outcomes of acute myocardial infarction (AMI) patients have been studied; however, those of recent myocardial infarction (RMI) patients remain unclear. This study aimed to clarify characteristics, treatment strategy, and in-hospital outcomes of RMI patients in the Tokyo CCU network database.Methods and Results:In total, 1,853 RMI and 12,494 AMI patients from the Tokyo CCU network database during 2013-2016 were compared. Both RMI and AMI were redefined by onset times of 2-28 days and ≤24 h, respectively. The RMI group had a higher average age (70.4±12.9 vs. 68.0±13.4 years, P<0.001), more women (27.6% vs. 23.6%, P<0.001), lower proportion of patients with chest pain as the chief complaint (75.2% vs. 83.6%, P<0.001), higher prevalence of diabetes mellitus (35.9% vs. 31.0%, P<0.001), and higher mechanical complication incidence (3.0% vs. 1.5%, P<0.001) than did the AMI group. Thirty-day mortality was comparable (5.3% vs. 5.8%, P=0.360); major causes of death were cardiogenic shock and mechanical complications in the AMI and RMI groups, respectively. Death from mechanical complications (not onset time) in the AMI group plateaued almost 1 week after hospitalization, whereas it continued to increase in the RMI group. Both RMI and AMI patients have distinctive clinical features, sequelae, and causes of death. Although treatment of RMI patients adhered to guidelines, it was insufficient, and death from mechanical complications continues to increase.

Sections du résumé

BACKGROUND
Characteristics and treatment outcomes of acute myocardial infarction (AMI) patients have been studied; however, those of recent myocardial infarction (RMI) patients remain unclear. This study aimed to clarify characteristics, treatment strategy, and in-hospital outcomes of RMI patients in the Tokyo CCU network database.Methods and Results:In total, 1,853 RMI and 12,494 AMI patients from the Tokyo CCU network database during 2013-2016 were compared. Both RMI and AMI were redefined by onset times of 2-28 days and ≤24 h, respectively. The RMI group had a higher average age (70.4±12.9 vs. 68.0±13.4 years, P<0.001), more women (27.6% vs. 23.6%, P<0.001), lower proportion of patients with chest pain as the chief complaint (75.2% vs. 83.6%, P<0.001), higher prevalence of diabetes mellitus (35.9% vs. 31.0%, P<0.001), and higher mechanical complication incidence (3.0% vs. 1.5%, P<0.001) than did the AMI group. Thirty-day mortality was comparable (5.3% vs. 5.8%, P=0.360); major causes of death were cardiogenic shock and mechanical complications in the AMI and RMI groups, respectively. Death from mechanical complications (not onset time) in the AMI group plateaued almost 1 week after hospitalization, whereas it continued to increase in the RMI group.
CONCLUSIONS
Both RMI and AMI patients have distinctive clinical features, sequelae, and causes of death. Although treatment of RMI patients adhered to guidelines, it was insufficient, and death from mechanical complications continues to increase.

Identifiants

pubmed: 32713883
doi: 10.1253/circj.CJ-20-0333
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1511-1518

Auteurs

Ryosuke Ito (R)

Tokyo CCU Network Scientific Committee.
Department of Cardiology, Tokyo Medical University Hospital.

Jun Yamashita (J)

Tokyo CCU Network Scientific Committee.

Taishiro Chikamori (T)

Department of Cardiology, Tokyo Medical University Hospital.

Seita Kondo (S)

Tokyo CCU Network Scientific Committee.

Yuya Mitsuhashi (Y)

Tokyo CCU Network Scientific Committee.

Hiroshi Iwata (H)

Tokyo CCU Network Scientific Committee.

Mike Saji (M)

Tokyo CCU Network Scientific Committee.

Taku Asano (T)

Tokyo CCU Network Scientific Committee.

Kohei Wakabayashi (K)

Tokyo CCU Network Scientific Committee.

Kazuyuki Yahagi (K)

Tokyo CCU Network Scientific Committee.

Toshiro Shinke (T)

Tokyo CCU Network Scientific Committee.

Takaaki Mase (T)

Tokyo CCU Network Scientific Committee.

Kaito Abe (K)

Tokyo CCU Network Scientific Committee.

Hideki Miyachi (H)

Tokyo CCU Network Scientific Committee.

Satoshi Higuchi (S)

Tokyo CCU Network Scientific Committee.

Mikio Kishi (M)

Tokyo CCU Network Scientific Committee.

Hiroyuki Tanaka (H)

Tokyo CCU Network Scientific Committee.

Masao Yamasaki (M)

Tokyo CCU Network Scientific Committee.

Katsumi Miyauchi (K)

Tokyo CCU Network Scientific Committee.

Takeshi Yamamoto (T)

Tokyo CCU Network Scientific Committee.

Ken Nagao (K)

Tokyo CCU Network Scientific Committee.

Morimasa Takayama (M)

Tokyo CCU Network Scientific Committee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH